Waller, Jamarius P.
Burke, Stephen P.
Engel, Jason
Chade, Alejandro R.
Bidwell, Gene L. III
Funding for this research was provided by:
National Institutes of Health (1F31HL15118001, R41DK109737, R41DK109737)
American Heart Association (18IPA34170267)
Article History
Received: 2 November 2020
Accepted: 4 March 2021
First Online: 18 March 2021
Competing interests
: A.R.C. and G.L.B. are inventors on intellectual property related to this technology. G.L.B. is owner of Leflore Technologies, LLC, a private company working to develop ELP-based drug delivery technologies. Leflore Technologies was the recipient of NIH Small Business Technology Transfer grant R41DK109737, which partially supported this work. All other authors have no conflicts of interest.